Pharmaceuticals,
Год журнала:
2024,
Номер
17(1), С. 130 - 130
Опубликована: Янв. 18, 2024
Background:
Epilepsy
is
a
chronic
brain
disease
affecting
millions
of
people
worldwide,
but
little
known
about
the
impact
anti-seizure
medications
on
redox
homeostasis.
Methods:
This
study
aimed
to
compare
effects
long-term
use
oral
in
monotherapy
(lamotrigine,
carbamazepine,
and
valproate)
antioxidant
enzymes:
superoxide
dismutase,
catalase,
glutathione
peroxidase,
reductase,
haemoglobin,
methaemoglobin
content
erythrocytes,
concentrations
total
proteins
thiols,
nitrites,
lipid
peroxides
plasma
epilepsy
patients
drug-naïve
patients.
Results:
The
results
showed
that
lamotrigine
therapy
led
lower
dismutase
activity
(p
<
0.005)
thiols
0.01)
compared
controls.
On
other
hand,
with
carbamazepine
increased
nitrite
levels
reduced
0.005).
In
valproate
group,
only
decrease
catalase
was
observed
Canonical
discriminant
analysis
composition
enzymes
erythrocytes
different
for
both
groups,
while
controls
were
separated
from
all
others.
Conclusions:
Monotherapy
discretely
alters
homeostasis,
followed
by
distinct
relationships
between
components.
Pharmaceuticals,
Год журнала:
2025,
Номер
18(3), С. 382 - 382
Опубликована: Март 7, 2025
Background/Objectives:
Epilepsy
is
a
complex
neurological
disorder
with
strong
link
to
oxidative
stress,
which
contributes
seizure
susceptibility
and
neuronal
damage.
This
study
aims
investigate
the
effects
of
curcumin
(Cur),
sodium
valproate
(VPA),
mitocurcumin
(MitoCur),
mitochondria-targeted
curcumin,
on
behavioral
stress
parameters
in
zebrafish
model
pentylenetetrazole
(PTZ)-induced
seizures.
Methods:
Adult
were
exposed
two
concentrations
(0.25
0.5
µM
for
Cur
MitoCur;
0.25
mM
VPA).
Behavioral
assessments,
including
locomotion,
spatial
exploration,
directional
movement,
conducted
using
EthoVision
XT
tracking
software.
Oxidative
markers,
superoxide
dismutase
(SOD),
malondialdehyde
(MDA),
glutathione
peroxidase
(GPx),
total
antioxidant
status
(TAS),
analyzed
brain
homogenates.
Results:
analyses
indicated
dose-dependent
effects,
higher
doses
generally
reducing
activity.
MitoCur
at
enhanced
defenses
reduced
damage,
while
exhibited
pro-oxidant
shift.
VPA
improved
TAS
without
significantly
altering
MDA
levels.
Conclusions:
These
findings
emphasize
importance
dose
optimization
antioxidant-based
epilepsy
treatments
highlight
potential
as
targeted
therapeutic
option.
Biomarker Research,
Год журнала:
2024,
Номер
12(1)
Опубликована: Ноя. 19, 2024
Abstract
Epilepsy
remains
a
prevalent
chronic
neurological
disease
that
is
featured
by
aberrant,
recurrent
and
hypersynchronous
discharge
of
neurons
poses
great
challenge
to
healthcare
systems.
Although
several
therapeutic
interventions
are
successfully
utilized
for
treating
epilepsy,
they
can
merely
provide
symptom
relief
but
cannot
exert
disease-modifying
effect.
Therefore,
it
urgent
need
explore
other
potential
mechanism
develop
novel
approach
delay
the
epileptic
progression.
Since
approximately
30
years
ago,
histone
deacetylases
(HDACs),
versatile
epigenetic
regulators
responsible
gene
transcription
via
binding
histones
or
non-histone
substrates,
have
grabbed
considerable
attention
in
drug
discovery.
There
also
substantial
evidences
supporting
aberrant
expressions
and/activities
HDAC
isoforms
reported
epilepsy
inhibitors
(HDACi)
been
purposes
this
condition.
However,
specific
mechanisms
underlying
role
HDACs
progression
not
fully
understood.
Herein,
we
reviewed
basic
information
HDACs,
summarized
recent
findings
associated
with
roles
diverse
subunits
discussed
regulatory
which
affected
development
epilepsy.
Additionally,
provided
brief
discussion
on
as
promising
targets
treatment,
serving
valuable
reference
study
clinical
translation
field.
Nanomedicine,
Год журнала:
2024,
Номер
19(9), С. 811 - 835
Опубликована: Март 6, 2024
Ischemic
stroke,
prevalent
among
the
elderly,
necessitates
attention
to
reperfusion
injury
post
treatment.
Limited
drug
access
brain,
owing
blood–brain
barrier,
restricts
clinical
applications.
Identifying
efficient
carriers
capable
of
penetrating
this
barrier
is
crucial.
Blood–brain
transporters
play
a
vital
role
in
nutrient
transport
brain.
Recently,
nanoparticles
emerged
as
carriers,
enhancing
permeability
via
surface-modified
ligands.
This
article
introduces
structure,
elucidates
pathogenesis,
compiles
ischemic
stroke
treatment
drugs,
explores
nanomaterials
for
encapsulation
and
emphasizes
their
advantages
over
conventional
drugs.
Utilizing
drug-delivery
systems
offers
targeting
efficiency
benefits
absent
traditional
The
prospects
nanomedicine
are
promising.
Journal of Integrative Neuroscience,
Год журнала:
2024,
Номер
23(6), С. 113 - 113
Опубликована: Июнь 13, 2024
Excessively
high
or
synchronized
neuronal
activity
in
the
brain
is
underlying
cause
of
epilepsy,
a
condition
central
nervous
system.
Epilepsy
caused
mostly
by
an
imbalance
inhibitory
and
excitatory
neural
networks.
Recurrent
prolonged
seizures
lead
to
death,
which
turn
promotes
epileptogenesis
epileptic
seizures.
Ferrous
ion-mediated
cell
death
known
as
ferroptosis,
due
accumulation
lipid
peroxidation
products
resulting
from
compromise
glutathione
(GSH)-dependent
antioxidant
The
pathophysiology
epilepsy
has
been
linked
anomalies
peroxidase
4
(GPX4)/GSH
redox
pathway,
peroxidation,
iron
metabolism.
Studies
have
shown
that
inhibiting
ferroptosis
may
alleviate
cognitive
impairment
decrease
seizures,
indicating
it
neuroprotective.
With
hope
aiding
development
more
novel
approaches
for
management
this
research
aimed
examine
role
disease.
Journal of Neuroimmune Pharmacology,
Год журнала:
2025,
Номер
20(1)
Опубликована: Янв. 7, 2025
Abstract
Empagliflozin
(EMPA)
is
one
of
the
sodium/glucose
cotransporter
2
(SGLT2)
inhibitors
that
has
been
recently
approved
for
treatment
diabetes
mellitus
type
II.
Recently,
EMPA
shown
protective
effects
in
different
neurological
disorders,
besides
its
antidiabetic
activity.
Kindling
a
relevant
model
to
study
epilepsy
and
neuroplasticity.
This
aimed
investigate
potential
(1
3
mg/kg
orally)
against
convulsant
induced
by
pentylenetetrazole
(PTZ)
using
modified
window-
(win-)
PTZ
kindling
protocol.
The
biochemical
dysfunction
hippocampal
damage
were
profoundly
reversed
dose-dependent
manner,
as
evidenced
significant
increase
reduced
glutathione
(GSH)
decrease
malondialdehyde
(MDA)
contents.
Furthermore,
counteracted
PTZ-induced
neuronal
region,
confirmed
histopathological
examination
tissues.
impaired
astrocytosis
showed
an
antiapoptotic
effect
through
reduction
glial
fibrillary
acidic
protein
(GFAP)
BCL2-Associated
X
Protein
(BAX)
expressions,
respectively.
Interestingly,
exhibited
antiepileptic
seizures
significantly
reducing
PAS
domain
4
(Npas4),
cyclic
adenosine
monophosphate
(cAMP)
response
element
binding
(CREB)
enhancing
brain-derived
neurotrophic
factor
(BDNF)-tropomyosin
receptor
kinase
B
(TrkB)
pathway,
which
are
found
be
involved
epileptogenesis,
eventually
leading
improvement
behavioral
impairments
PTZ.
Hence,
these
results
further
prospective
insights
neuroprotective
agent.
Graphical
Abstract
Objective
Idiopathic
epilepsy
(IE)
is
the
most
common
chronic
neurological
disease
in
dogs
and
an
established
natural
animal
model
for
human
types
with
genetic
unknown
etiology.
However,
metabolic
pathways
underlying
IE
remain
largely
unknown.
Methods
Plasma
samples
of
healthy
(
n
=
39)
49)
were
metabolically
profiled
121
known
target
metabolites)
fingerprinted
1825
untargeted
features)
using
liquid
chromatography
coupled
to
mass
spectrometry.
Dogs
classified
as
mild
phenotype
(MP;
22)
or
drug‐resistant
(DR;
27).
All
received
same
standard
adult
maintenance
diet
a
minimum
20
days
(35
±
11
days)
before
sampling.
Data
analyzed
combination
univariate
(one‐way
analysis
variance
Kruskal–Wallis
rank
sum
test),
multivariate
limma
,
orthogonal
partial
least
squares–discriminant
analysis),
pathway
enrichment
statistical
analysis.
Results
In
both
DR
MP
IE,
distinct
plasma
profile
fingerprint
compared
was
observed.
Metabolic
involved
these
alterations
included
oxidative
stress,
inflammation,
amino
acid
metabolism.
Moreover,
significantly
lower
concentrations
vitamin
B6
found
p
.001)
.005)
dogs.
Significance
Our
data
provide
new
insights
into
dogs,
further
substantiating
its
potential
humans
epilepsy,
reflected
by
related
changes
stress
metabolites
B6.
Even
more,
several
within
uncovered
offer
promising
therapeutic
targets
management
primarily
ultimately
humans.
Oxidative
damage
has
been
implicated
in
multiple
neurodegenerative
diseases,
including
epilepsy.
Selenium,
the
form
of
selenoproteins
is
an
integral
part
human
antioxidant
defense
system.
Though
a
relationship
between
altered
selenium
levels
and
epilepsy
reported,
limited
evidence
available
about
expression
pattern
epileptic
patients.
This
study
aimed
to
determine
serum
idiopathic
healthy
individuals.
Expression
profiling
(GPx1,
TRxR1
SEPW1)
both
at
mRNA
protein
was
also
evaluated.
Serum
30
patients
with
generalized
their
age
gender
matched
controls
were
measured.
Protein
Glutathione
Peroxidase
1
(GPx1),
Thioredoxin
Reductase
(TRxR1)
Selenoprotein
W
(SEPW1)
estimated
using
ELISA.
GPx1,
SEPW1
determined
qRT-PCR.
The
mean
values
for
cases
37.6
±
2.0
µmol/ml
38.9
2.7
µmol/ml,
respectively.
Selenium
significantly
lower
as
compared
(p
=
0.031).
No
statistically
significant
differences
observed
group.
GPx1
found
be
down
regulated
(0.34
0.13
folds
respectively)
whereas
SEPW
0.04
up
subjects.
deficiency
suggests
association
provides
information
status
Pakistani
population
helps
understanding
role
prevention